Faculty

Institution

Unit

Venue

Kevin Outterson

Professor of Health Law Ethics & Human Rights

Boston University

Affiliations

School of Public Health

Health Law, Policy & Management

Kevin Outterson is currently serving as a Health Law, Policy & Management Professor of Health Law Ethics & Human Rights at Boston University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Kevin Outterson

Boston University

Professor of Health Law Ethics & Human Rights

You can click a keyword to filter the displayed items

public health health policy global health antimicrobial resistance antibiotics drug resistance antibiotic resistance pharmacology infection control antimicrobial stewardship health law health economics antimicrobial agents clinical microbiology legal medicine social science research drug policy hospital infections pharmacoeconomics emerging infectious diseases antimicrobial susceptibility drug delivery applied microbiology public health ethics drug development antimicrobial chemotherapy clinical infectious disease antimicrobial resistance genes antibiotic development pharmaceutical innovation drug discovery clinical research clinical epidemiology respiratory medicine preventive medicine clinical infection healthcare ethics public domain enzyme inhibition communicable diseases medical microbiology regulatory approval public health law pharmaceutical technology pharmaceutical research pharmaceutical sciences implementation strategies clinical implementation pharmacoepidemiology antibiotic innovation antibiotic research patient access health canada global pull incentives united states global public health multidrug-resistant bacteria virus research cancer care pharmacotherapy bacteriology treatment and prevention molecular microbiology bacteriophages cancer management cancer treatment cancer prevention clinical mycology vaccine development infectious disease modelling cost effectiveness antibiotic-resistant bacteria escalating challenges broken market diagnostics development antibiotic reimbursement medicine patent information pharmaceutical practice

Notable Scholarly Works

Notable Federal Grants

Collaborators

Analyzing Antimicrobial Resistance as a Series of Collective Action Problems. Policy Studies Journal (2024)

Isaac WeldonKathleen LiddellSusan Rogers Van KatwykSteven J. HoffmanTimo MinssenKevin OuttersonStephanie PalmerA. M. ViensJorge Viñuales

public healthantimicrobial resistancecollective action problemspolicy analysis

Changes in Revenues Associated With Antimicrobial Reimbursement Reforms in Germany. Humanities and Social Sciences Communications (2024)

Matt McEnanyKevin Outterson

humanitiesantimicrobial reimbursement reformssocial sciences

Conference Report of the 2024 Antimicrobial Resistance Meeting. npj Antimicrobials and Resistance (2024)

Charlotte E. ChongThi Mui PhamMegan E. CareyBryan A. WeeMona L. TaoukJavier F. FavieresCatrin E. MooreZoe A. DysonCherry LimConnor L. BrownDeborah WilliamsonLulla OpatowskiKevin OuttersonKaryn M. MukiriNorelle L. SherrySabiha Y. EssackSylvain BrisseYonatan H. GradKate S. Baker

antimicrobial agentsantimicrobial resistance genesantimicrobial resistanceantimicrobial stewardshipantibiotic resistanceantimicrobial resistance meetingantimicrobial susceptibilitydrug resistanceinfectious diseasesantimicrobial chemotherapy

Expanding Antibiotic, Vaccine, and Diagnostics Development and Access to Tackle Antimicrobial Resistance. The Lancet (2024)

Ramanan LaxminarayanIsabella ImpalliRadha RangarajanJennifer CohnKavi RamjeetBetsy Wonderly TrainorSteffanie StrathdeeNithima SumpraditDaniel BermanHeiman WertheimKevin OuttersonPadmini SrikantiahUrsula Theuretzbacher

pharmacoepidemiologyantimicrobial stewardshipclinical microbiologyvaccinationinfectious diseasespublic healthvaccinesmedicineantimicrobial resistanceantibiotic resistanceantibioticshospital infectionsdiagnostics developmentantimicrobial agentsvaccine developmentpreventive medicinemedical microbiologyinfection controldrug resistance

Implementing an EU Pull Incentive for Antimicrobial Innovation and Access: Blueprint for Action. The Lancet Microbe (2024)

Michael AndersonAdrian TowseKevin OuttersonElias Mossialos

public healthimplementation strategiesimplementation researchantimicrobial innovationeu pull incentiveglobal healthhealth policy

The Time to Address the Antibiotic Pipeline and Access Crisis is Now. The Lancet (2024)

Manica BalasegaramKevin OuttersonJohn-Arne Røttingen

pharmacoepidemiologyantimicrobial stewardshipclinical microbiologyuniversal accessinfectious diseasespublic healthmedicineantimicrobial resistanceantibiotic resistanceaccess crisisantibioticsantimicrobial agentsinternational healthantibiotic pipelinepublic health preparednessinfection controlcrisis managementdrug resistancehealthcare-associated infections

Workhorse Antibiotics Are in Jeopardy: Resistance Trajectories and the Need for an R D Response. (2024)

McDonnell, AnthonyKlemperer, KatherineMadden, JacobMorton, AlecKhine-Zaw, YuzanaColson, AbigailAmir, AfreenishApisarnthanarak, AnuchaEl-Sharif, AmanyGales, Ana CristinaGigante, ValeriaHuang, XunIredell, JonathanOhmagari, NorioSati, HatimSharland, MikeSong, Jae-HoonStelling, JohnTaneja, NeelamEssack, Sabiha YusufOutterson, Kevin

workhorse antibioticsmedicineantimicrobial resistanceantibiotic resistancedrug resistanceantibioticsresistance trajectories

Global Pull Incentives for Better Antibacterials: The UK Leads the Way. Applied Health Economics and Health Policy (2023)

Kevin OuttersonJohn H. Rex

public healthbetter antibacterialsglobal pull incentiveshealth economicshealth policy

Trends in the Global Antibiotics Market. Nature Reviews Drug Discovery (2023)

Jacob MaddenKevin Outterson

global antibiotics marketclinical microbiologyeconomic influencesseafood industrybiosensorsinternational demanddrug analysisantibioticsdrug deliverydermatologytherapeutic targetsimmunologyenzyme inhibitioninfection controlinternational financial marketsdrug discoveryregulatory approvalmicrobiologyillegal dumping

A Pandemic Instrument Can Start Turning Collective Problems Into Collective Solutions by Governing the Common-Pool Resource of Antimicrobial Effectiveness. The Journal of Law Medicine & Ethics (2022)

Isaac WeldonKathy LiddellSusan Rogers Van KatwykSteven J. HoffmanTimo MinssenKevin OuttersonStephanie PalmerA.M. ViensJorge Viñuales

public healthcommon-pool resourcehealth lawpandemic instrumentantimicrobial effectivenesscovid-19 pandemicinternational healthcollective problemsglobal healthcollective solutionslegal medicinehealth policy

1
2
3
4
5
11
10 / page

Kevin Outterson

Professor of Health Law Ethics & Human Rights

Boston University

Affiliations

School of Public Health

Health Law, Policy & Management

Kevin Outterson is currently serving as a Health Law, Policy & Management Professor of Health Law Ethics & Human Rights at Boston University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Kevin Outterson

Boston University

Professor of Health Law Ethics & Human Rights

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Analyzing Antimicrobial Resistance as a Series of Collective Action Problems. Policy Studies Journal (2024)

Isaac WeldonKathleen LiddellSusan Rogers Van KatwykSteven J. HoffmanTimo MinssenKevin OuttersonStephanie PalmerA. M. ViensJorge Viñuales

public healthantimicrobial resistancecollective action problemspolicy analysis

Changes in Revenues Associated With Antimicrobial Reimbursement Reforms in Germany. Humanities and Social Sciences Communications (2024)

Matt McEnanyKevin Outterson

humanitiesantimicrobial reimbursement reformssocial sciences

Conference Report of the 2024 Antimicrobial Resistance Meeting. npj Antimicrobials and Resistance (2024)

Expanding Antibiotic, Vaccine, and Diagnostics Development and Access to Tackle Antimicrobial Resistance. The Lancet (2024)

Implementing an EU Pull Incentive for Antimicrobial Innovation and Access: Blueprint for Action. The Lancet Microbe (2024)

Michael AndersonAdrian TowseKevin OuttersonElias Mossialos

public healthimplementation strategiesimplementation researchantimicrobial innovationeu pull incentiveglobal healthhealth policy

The Time to Address the Antibiotic Pipeline and Access Crisis is Now. The Lancet (2024)

Manica BalasegaramKevin OuttersonJohn-Arne Røttingen

Workhorse Antibiotics Are in Jeopardy: Resistance Trajectories and the Need for an R D Response. (2024)

workhorse antibioticsmedicineantimicrobial resistanceantibiotic resistancedrug resistanceantibioticsresistance trajectories

Global Pull Incentives for Better Antibacterials: The UK Leads the Way. Applied Health Economics and Health Policy (2023)

Kevin OuttersonJohn H. Rex

public healthbetter antibacterialsglobal pull incentiveshealth economicshealth policy

Trends in the Global Antibiotics Market. Nature Reviews Drug Discovery (2023)

Jacob MaddenKevin Outterson

Isaac WeldonKathy LiddellSusan Rogers Van KatwykSteven J. HoffmanTimo MinssenKevin OuttersonStephanie PalmerA.M. ViensJorge Viñuales

1
2
3
4
5
11
10 / page

Similar Faculty Members

Daniel Uslan

Institution

University of California, Los Angeles

infectious diseases (medical specialty)

hospital infection

Scott Burris

Institution

Temple University

public health

law

Scott Heysell

Institution

University of Virginia

equity interventions

drug resistance

Ruth Faden

Institution

Johns Hopkins University

public health

health policy

Yonatan Grad

Institution

Harvard University

infectious diseases

epidemiology

Scott Evans

Institution

George Washington University

hospital epidemiology

infectious diseases (medical specialty)

David Nix

Institution

University of Arizona

pharmacokinetics

infectious diseases

Eili Klein

Institution

Johns Hopkins University

infectious diseases

public health

Charlesnika Tyon Evans

Institution

Northwestern University

public health

infectious diseases

Ronald Bayer

Institution

Columbia University

treatment and prevention

health system

Similar Faculty Members

Daniel Uslan

Institution

University of California, Los Angeles

infectious diseases (medical specialty)

hospital infection

Scott Burris

Institution

Temple University

public health

law

Scott Heysell

Institution

University of Virginia

equity interventions

drug resistance

Ruth Faden

Institution

Johns Hopkins University

public health

health policy

Yonatan Grad

Institution

Harvard University

infectious diseases

epidemiology

Scott Evans

Institution

George Washington University

hospital epidemiology

infectious diseases (medical specialty)

David Nix

Institution

University of Arizona

pharmacokinetics

infectious diseases

Eili Klein

Institution

Johns Hopkins University

infectious diseases

public health

Charlesnika Tyon Evans

Institution

Northwestern University

public health

infectious diseases

Ronald Bayer

Institution

Columbia University

treatment and prevention

health system